Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Sunovion Must Regroup After Setback With Dasotraline In ADHD

Sat, 09/01/2018 - 6:57am

Sunovion must find a new path forward for its dasotraline in attention deficit/hyperactivity disorder (ADHD), following a complete response letter...

      Related Stories 

Amid Pharma ‘Landmarks’ Cipla Develops Tenofovir Prodrug

Fri, 08/31/2018 - 7:50am

Cipla’s chair Dr Yusuf Hamied highlighted a series of ‘landmarks’ along the company’s journey at its recent annual general meeting...

      Related Stories 

Pay Day For Reata As Kyowa Kirin Progresses Bardoxolone For Kidney Disease In Japan

Fri, 08/31/2018 - 7:29am

Reata reaps benefit from 2009 licensing deal with Kyowa Hakko Kirin for bardoxolone as transcription factor activator moves into pivotal...

      Related Stories 

Alnylam Switches Attention To Access After Onpattro EU Okay

Fri, 08/31/2018 - 7:24am

European approval is in the bag for Onpattro for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis but in a week...

      Related Stories 

TULIP Fever: AstraZeneca Catches Cold With Disappointing Lupus Data

Fri, 08/31/2018 - 7:24am

Another one of AstraZeneca’s more left-field product candidates, its investigational lupus therapy anifrolumab, has disappointed at Phase III.

      Related Stories 

Bayer To Ship Long-acting Hemophilia Infusion Jivi In A Jiffy

Thu, 08/30/2018 - 4:31pm

The company believes there is room in the market for its more standard-acting hemophilia A products Kogenate and Kovaltry, as...

      Related Stories 

Poxel Adds To NASH Pipeline With Novel Single-Isomer Pioglitazone

Thu, 08/30/2018 - 7:16am

Some ground-breaking chemistry has been used to produce a single isomer of pioglitazone, which has been acquired by France's Poxel...

      Related Stories 

Ferring Plots Genomics Path With Celmatix Pact

Thu, 08/30/2018 - 6:24am

The firms have inked a collaboration which aims to explore individual differences in women’s responses to IVF treatment, improve success...

      Related Stories 

Deal Watch: Emergent Strikes Again, Acquiring Adapt And Its Opioid Overdose Drug For $635m

Wed, 08/29/2018 - 2:04pm

Following its purchase of PaxVax earlier this month, Emergent is taking on Narcan nasal spray for opioid overdose as part...

      Related Stories 

Bayer Files Larotrectinib In EU As LOXO-292 Hurtles Towards The Market

Wed, 08/29/2018 - 8:59am

An EU filing by licensee Bayer puts Loxo Oncology’s larotrectinib on track to be the first tropomysosin receptor kinase inhibitor...

      Related Stories 

Executives On The Move: New Hires at Achillion And Bayer, And Promotions At Allegro Ophthalmics And Merz Pharma

Wed, 08/29/2018 - 6:44am

This week’s new appointments include C-level promotions at Allegro Ophthalmics, Merz Pharma and Athenex. In addition, new directors joined the...

      Related Stories 

BeyondSpring CEO On Plinabulin's Dual Regulatory Pathway For US and China

Wed, 08/29/2018 - 6:08am

BeyondSpring’s lead clinical asset, plinabulin, is currently in late-stage global registrational studies for the prevention of chemotherapy-induced neutropenia and treatment...

      Related Stories 

GSK Puts Tail End Brands On The Block In India

Wed, 08/29/2018 - 5:08am

GlaxoSmithKline is believed to be keen to divest close to a dozen tail-end brands across therapy groups including anti-infectives and...

      Related Stories 

Pages